Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
-
Narrated by:
-
By:
About this listen
Featuring an interview with Dr Rafael Fonseca, including the following topics:
· Safe management of bispecific antibodies and chimeric antigen receptor (CAR) T-cell therapy for patients with multiple myeloma (MM) (0:00)
· Sequencing bispecific antibodies and CAR T-cell therapy (10:40)
· Available data with and potential future clinical integration of belantamab mafodotin in the management of MM (16:03)
· Optimizing maintenance therapy for patients with MM (31:11)
· Novel management strategies for smoldering myeloma (36:29)
· Role of anti-CD38 antibodies in the up-front management of MM (41:41)
· Available data with cereblon E3 ligase modulatory drugs for MM (47:45)
CME information and select publications
What listeners say about Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.